Stem Cell-Derived Organoids as a Next-Generation Platform for Drug Toxicity and Efficacy Testing: Toward Replacing Animal Models in Regulatory Science.

Three-dimensional, self-organizing structures derived from stem cells, known as organoids, represent a groundbreaking advancement in preclinical drug development. Organoid-based platforms advance preclinical testing by providing an accurate represent…

Preview only. Read the full abstract at the source